VCYT EBITDA | VERACYTE, INC.

VERACYTE, INC. (VCYT) EBITDA

2026-06-30: Basis Reported; EBITDA $27.82M*; Operating income $22.98M; Depreciation and amortization $4.84M*.
2026-03-31: Basis Reported; EBITDA $28.08M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $42.49M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $28.21M*; Operating income $22.95M; Depreciation and amortization $5.27M*.

Complete source-backed ebitda history.

Available history: 2011-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$27.82M*	$22.98M	$4.84M*	$150.32M	18.51%*	$2.86M*	$45.83M*	(m)	$29.44M	(m)	$1.03M
2026-03-31	Reported	$28.08M	(m)	(m)	(m)	20.19%	$2.96M	$35.22M	(m)	$27.10M	(m)	$1.27M
2025-12-31	Reported	$42.49M	(m)	(m)	(m)	30.21%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$28.21M*	$22.95M	$5.27M*	$131.87M	21.39%*	$2.79M*	$44.76M*	(m)	$15.98M	(m)	-$248.00K
2025-06-30	Reported	$221.00K*	-$5.27M	$5.49M*	$130.16M	0.17%*	$1.29M*	$33.60M*	(m)	$16.26M	(m)	$2.23M
2025-03-31	Reported	$8.27M	(m)	(m)	(m)	7.22%	$1.82M	$5.36M	(m)	$17.72M	(m)	$381.00K
2024-12-31	Reported	$10.43M	(m)	(m)	(m)	8.79%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$17.89M*	$12.02M	$5.88M*	$115.86M	15.45%*	$2.24M*	$29.96M*	(m)	$17.57M	(m)	$1.69M
2024-06-30	Reported	$10.34M*	$4.61M	$5.74M*	$114.43M	9.04%*	$2.77M*	$29.57M*	(m)	$16.46M	(m)	$1.63M
2024-03-31	Reported	$934,000.00	(m)	(m)	(m)	0.96%	$2.13M	-$8.97M	(m)	$15.96M	(m)	-$44.00K
2023-12-31	Reported	-$29.17M	(m)	(m)	(m)	-29.71%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$24.42M*	-$31.74M	$7.32M*	$90.11M	-27.10%*	$2.80M*	$14.17M*	(m)	$13.32M	(m)	-$154.00K
2023-06-30	Reported	-$1.19M*	-$8.05M	$6.86M*	$90.32M	-1.32%*	$3.67M*	$16.67M*	(m)	$12.54M	(m)	$125.00K
2023-03-31	Reported	-$3.83M	(m)	(m)	(m)	-4.64%	$993.00K	-$2.17M	(m)	$12.77M	(m)	$0.00
2022-12-31	Reported	$1.14M	(m)	(m)	(m)	1.41%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$3.36M*	-$9.68M	$6.32M*	$75.59M	-4.44%*	$1.71M*	$7.03M*	(m)	$10.77M	(m)	-$152.00K
2022-06-30	Reported	-$4.24M*	-$10.73M	$6.49M*	$72.86M	-5.82%*	$2.51M*	-$363.00K*	(m)	$9.38M	(m)	-$115.00K
2022-03-31	Reported	-$8.69M	(m)	(m)	(m)	-12.82%	$2.45M	-$8.87M	(m)	$9.17M	(m)	-$3.00K
2021-12-31	Reported	-$5.93M	(m)	(m)	(m)	-8.81%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$10.54M*	-$16.68M	$6.14M*	$60.37M	-17.46%*	$1.81M*	-$1.39M*	(m)	$8.01M	(m)	-$1.35M
2021-06-30	Reported	-$2.97M*	-$7.47M	$4.50M*	$55.10M	-5.40%*	$1.53M*	$1.89M*	(m)	$6.25M	(m)	-$152.00K
2021-03-31	Reported	-$42.87M	(m)	(m)	(m)	-116.79%	$1.20M	-$40.56M	(m)	$5.34M	(m)	-$3.79M
2020-12-31	Reported	-$6.05M	(m)	(m)	(m)	-17.51%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$2.08M*	-$4.07M	$1.99M*	$31.12M	-6.67%*	$635.00K*	$1.75M*	(m)	$4.04M	(m)	$0.00
2020-06-30	Reported	-$9.09M*	-$11.05M	$1.96M*	$20.70M	-43.92%*	$649.00K*	-$8.42M*	(m)	$4.17M	(m)	$0.00
2020-03-31	Reported	-$10.23M	(m)	(m)	(m)	-32.86%	$665.00K	-$5.30M	(m)	$4.41M	(m)	$0.00
2019-12-31	Reported	-$6.92M	(m)	(m)	(m)	-23.26%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$796.00K*	-$1.76M	$967.00K*	$30.97M	-2.57%*	$232.00K*	-$1.56M*	(m)	$3.64M	(m)	$0.00
2019-06-30	Reported	-$2.18M*	-$3.10M	$924.00K*	$30.14M	-7.22%*	$659.00K*	-$2.46M*	(m)	$3.33M	(m)	$0.00
2019-03-31	Reported	-$1.12M	(m)	(m)	(m)	-3.80%	$765.00K	-$1.01M	(m)	$3.44M	(m)	(m)
2018-12-31	Reported	-$2.09M	(m)	(m)	(m)	-8.10%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$3.32M*	-$4.30M	$981.00K*	$23.47M	-14.16%*	$659.00K*	-$1.78M*	(m)	$3.42M	(m)	(m)
2018-06-30	Reported	-$4.93M*	-$5.92M	$989.00K*	$22.75M	-21.66%*	$534.00K*	-$3.10M*	(m)	$4.60M	(m)	(m)
2018-03-31	Reported	-$7.98M	(m)	(m)	(m)	-39.79%	$227.00K	-$7.41M	(m)	$3.67M	(m)	(m)
2017-12-31	Reported	-$5.04M	(m)	(m)	(m)	-25.73%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$5.38M*	-$6.37M	$993.00K*	$17.52M	-30.68%*	$727.00K*	-$5.10M*	(m)	$3.05M	(m)	(m)
2017-06-30	Reported	-$5.67M*	-$6.61M	$944.00K*	$18.41M	-30.78%*	$113.00K*	(m)	(m)	$3.60M	(m)	(m)
2017-03-31	Reported	-$6.62M	(m)	(m)	(m)	-40.26%	$615.00K	(m)	(m)	$4.03M	(m)	(m)
2016-12-31	Reported	-$2.76M	(m)	(m)	(m)	-15.13%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$3.99M*	-$4.89M	$899.00K*	(m)	(m)	$173.00K*	(m)	(m)	$4.01M	(m)	(m)
2016-06-30	Reported	-$9.55M*	-$10.49M	$941.00K*	(m)	(m)	$732.00K*	(m)	(m)	$4.27M	(m)	(m)
2016-03-31	Reported	-$8.99M	(m)	(m)	(m)	-66.34%	$2.85M	(m)	(m)	$3.46M	(m)	(m)
2015-12-31	Reported	-$7.34M	(m)	(m)	(m)	-52.26%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$8.24M*	-$8.89M	$646.00K*	(m)	(m)	$1.12M*	(m)	(m)	$3.56M	(m)	(m)
2015-06-30	Reported	-$8.43M*	-$9.07M	$644.00K*	(m)	(m)	$341.00K*	(m)	(m)	$3.10M	(m)	(m)
2015-03-31	Reported	-$7.2M	(m)	(m)	(m)	-64.19%	$511.00K	(m)	(m)	$2.79M	(m)	(m)
2014-12-31	Reported	-$7.72M	(m)	(m)	(m)	-63.26%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$7.52M*	-$7.81M	$292.00K*	(m)	(m)	$587.00K*	(m)	(m)	$2.23M	(m)	(m)
2014-06-30	Reported	-$6.28M*	-$6.56M	$277.00K*	(m)	(m)	$780.00K*	(m)	(m)	$2.24M	(m)	(m)
2014-03-31	Reported	-$6.31M	(m)	(m)	(m)	-84.42%	$124.00K	(m)	(m)	$2.13M	(m)	(m)
2013-12-31	Reported	-$5.48M	(m)	(m)	(m)	-80.14%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$5.81M*	-$6.10M	$289.00K*	(m)	(m)	$120.00K*	(m)	(m)	$2.03M	(m)	(m)
2013-06-30	Reported	-$5.19M*	-$5.42M	$231.00K*	(m)	(m)	$385.00K*	(m)	(m)	$1.90M	(m)	(m)
2013-03-31	Reported	-$5.7M	(m)	(m)	(m)	-129.93%	$556.00K	(m)	(m)	$2.01M	(m)	(m)
2012-12-31	Reported	-$4.94M	(m)	(m)	(m)	-110.75%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	(m)	-$4.94M	(m)	(m)	(m)	(m)	(m)	(m)	$1.73M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$79.19M	(m)	(m)	(m)	15.31%	$9.68M	$136.31M	(m)	$70.81M	(m)	$1.85M
2024-12-31	Reported	$39.6M	(m)	(m)	(m)	8.88%	$11.29M	$75.10M	(m)	$69.29M	(m)	$1.61M
2023-12-31	Reported	-$58.61M	(m)	(m)	(m)	-16.23%	$9.96M	$44.22M	(m)	$57.30M	(m)	-$2.21M
2022-12-31	Reported	-$15.15M	(m)	(m)	(m)	-5.11%	$8.55M	$7.54M	(m)	$40.60M	(m)	$133.00K
2021-12-31	Reported	-$62.31M	(m)	(m)	(m)	-28.39%	$5.38M	-$31.62M	(m)	$29.84M	(m)	-$6.09M
2020-12-31	Reported	-$27.45M	(m)	(m)	(m)	-23.36%	$2.84M	-$9.71M	(m)	$17.20M	(m)	$0.00
2019-12-31	Reported	-$11.01M	(m)	(m)	(m)	-9.15%	$2.76M	-$3.23M	(m)	$14.85M	(m)	$0.00
2018-12-31	Reported	-$18.31M	(m)	(m)	(m)	-19.90%	$1.87M	-$13.52M	(m)	$14.82M	(m)	$0.00
2017-12-31	Reported	-$22.7M	(m)	(m)	(m)	-31.54%	$1.75M	-$23.91M	(m)	$13.88M	(m)	$0.00
2016-12-31	Reported	-$25.29M	(m)	(m)	(m)	-38.86%	$4.21M	-$27.98M	(m)	$15.32M	(m)	$0.00
2015-12-31	Reported	-$31.21M	(m)	(m)	(m)	-63.05%	$6.17M	-$26.96M	(m)	$12.80M	(m)	$0.00
2014-12-31	Reported	-$27.83M	(m)	(m)	(m)	-72.88%	$2.02M	(m)	(m)	$9.80M	(m)	$0.00
2013-12-31	Reported	-$22.17M	(m)	(m)	(m)	-101.33%	$1.33M	(m)	(m)	$7.81M	(m)	$0.00
2012-12-31	Reported	-$18.22M	(m)	(m)	(m)	-156.72%	$1.46M	(m)	(m)	$6.61M	(m)	(m)
2011-12-31	Reported	-$14.66M	(m)	(m)	(m)	-554.06%	$276.00K	(m)	(m)	$6.68M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Celcuity Inc. (CELC)	United States	$3.887B	-22.62
CareDx, Inc. (CDNA)	United States	$3.174B	13.21
GRAIL, Inc. (GRAL)	United States	$5.591B	-7.78
RadNet, Inc. (RDNT)	United States	$5.611B	-229.65
Fortrea Holdings Inc. (FTRE)	United States	$1.903B	-19.43
Personalis, Inc. (PSNL)	United States	$1.769B	-13.30
CASTLE BIOSCIENCES INC (CSTL)	United States	$1.074B	-37.45
Lumexa Imaging Holdings, Inc. (LMRI)	United States	$0.951B
Fulgent Genetics, Inc. (FLGT)	United States	$0.593B	-6.70
BIODESIX INC (BDSX)	United States	$0.312B